These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17690133)

  • 1. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha.
    Yang Q; Nagano T; Shah Y; Cheung C; Ito S; Gonzalez FJ
    Toxicol Sci; 2008 Jan; 101(1):132-9. PubMed ID: 17690133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alpha.
    Foreman JE; Chang SC; Ehresman DJ; Butenhoff JL; Anderson CR; Palkar PS; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2009 Jul; 110(1):204-11. PubMed ID: 19359353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).
    Roberts RA; James NH; Woodyatt NJ; Macdonald N; Tugwood JD
    Carcinogenesis; 1998 Jan; 19(1):43-8. PubMed ID: 9472691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
    Gonzalez FJ; Shah YM
    Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis.
    James NH; Gill JH; Brindle R; Woodyatt NJ; Macdonald N; Rolfe M; Hasmall SC; Tugwood JD; Holden PR; Roberts RA
    Toxicol Lett; 1998 Dec; 102-103():91-6. PubMed ID: 10022238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α.
    Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K
    Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARα(PAC) mice due to dysregulated bile acid synthesis.
    Liu HX; Hu Y; French SW; Gonzalez FJ; Wan YJ
    Oncotarget; 2015; 6(12):9686-700. PubMed ID: 25991671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent update on the PPAR alpha-null mouse.
    Gonzalez FJ
    Biochimie; 1997; 79(2-3):139-44. PubMed ID: 9209711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.
    Mukherjee R; Jow L; Noonan D; McDonnell DP
    J Steroid Biochem Mol Biol; 1994 Nov; 51(3-4):157-66. PubMed ID: 7981125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis.
    Yang Q; Ito S; Gonzalez FJ
    Carcinogenesis; 2007 Jun; 28(6):1171-7. PubMed ID: 17331954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    Bisgaier CL; Oniciu DC; Srivastava RAK
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):3-10. PubMed ID: 29621036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors: structures and function.
    Tugwood JD; Aldridge TC; Lambe KG; Macdonald N; Woodyatt NJ
    Ann N Y Acad Sci; 1996 Dec; 804():252-65. PubMed ID: 8993548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Cwinn MA; Jones SP; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osthol regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine.
    Sun F; Xie ML; Xue J; Wang HB
    Phytomedicine; 2010 Jul; 17(8-9):669-73. PubMed ID: 20042322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice.
    Rachid TL; Penna-de-Carvalho A; Bringhenti I; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
    Cell Biochem Funct; 2015 Jun; 33(4):249-56. PubMed ID: 25959716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
    Macdonald N; Holden PR; Roberts RA
    Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epitope-tagging system for studying regulation of the peroxisome proliferator activated receptor alpha (PPAR alpha).
    Owens JM; Tugwood JD; Gibson GG
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):325-8. PubMed ID: 9512929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.